Chondroitin Sulfate Market Products, Services and Solutions from 2019 to 2026

​The worldwide ​chondroitin sulfate market worth is estimated to succeed in around US$ 1.5 billion by 2026 and can develop at CAGR above 3.3% over the forecast time frame 2019 - 2026.  The report provides analysis of global Chondroitin Sulfate market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.

Increased use of joint health supplements as a consequence of increased arthritis among obese and geriatric populations is expected to increase item requirement.

The main variables causing demand for the item are clinical efficiency and the joint health advantages provided. The increasing use of sodium chondroitin pharmaceutical grade sulfate is expected to stimulate development in the sector to heal osteoarthritis. The market is extremely affected by the availability of Chinese dominated products, which are poor and variable in quality, concentration, lacking traceability and deliberate adulteration in the global nutraceutical sector. There are therefore many possibilities for producers and distributors of raw materials to supply quality and standardized products through an auditable supply chain.

Industry challenges include sodium chondroitin sulfate adulteration and the implementation of fresh joint hygiene products. Fluctuating costs of raw materials are expected to adversely affect the item. However, the focus on cost-effective processes will probably boost volumetric manufacturing. The United States, Germany, the United Kingdom, Japan and Brazil are among the main prospective markets for pharmaceutical and nutraceutical sodium chondroitine sulfate.

Download Free Sample Report Pages for Better Understanding @https://www.acumenresearchandconsulting.com/request-sample/1558

Key Findings

The US market is expected to achieve around 600 tonnes by 2026 in terms of quantity.

Chondroitin sulfate is controlled and endorsed in Europe as a symptomatic slow-acting osteoarthritis medication (SYSADOA) and its consumption together with glucosamine is preferable.

NutriScience Innovations, LLC, a prominent US sodium chondroitin sulfate company, utilizes European raw materials and generates high-grade 90 percent USP chondroitin sulfate without the use of organic solvents.

Chondroitin sulfate is also regarded as Glycosaminoglycan sulfate (GAG). Chondroitin sulfate is made up of a massive alternating sugar chain including glucuronic acid and N-acetylgalactosamine. Chondroitin sulfate is a chemical compound discovered in human connective tissue discovered in cartilage and body joints. Commercial chondroitin sulfate is produced from a variety of animal sources including pigs, bovine, chicken, fish, shark, crocodiles and other livestock. Chondroitin sulfate is used to stop the development of osteoarthritis as an alternative medicine. Chondroitin sulfate also contributes to a reduction of joint pain and inflammation. Regular chondroitin sulfate intake contributes to better joint activities. Commercial chondroitin sulfate is a glucosamine and chondroitin sulfate combination. Chondroitin sulphate can also serve as an eye drop for sore eyes, in addition to enhancing the joint function, in veterinary applications.

The demand for chondroitin sulfate is anticipated to grow at a greater pace from dietary supplement producers in the near future due to growing healthcare, population aging and a greater emphasis on preventative care and self-care through dietary supplements in order to preserve health and wellbeing. In addition, demand for Chondroitin sulfate increases with rising health-conscious customers and the aging population for joint health supplements.

Key Players & Strategies

Major players included in this report are Bioiberica S.A.U.; Qingdao Wan tulmin Biological Products Co. Ltd.; Sigma-Aldrich, Inc.; HeBei SanXin Industrial Group; Sino Siam Biotechnique Company Limited; Bio-gen Extracts Private Limited; TSI Group Ltd.; ZPD; and SEIKAGAKU CORPORATION.

Key developed economies producers such as the US, France, Germany and the UK. The majority supply to important actors in the nutraceutical and pharmaceutical industries of sodium chondroitin sulfate. The development of osteoarthritis and rising consumption of dietary supplements can be ascribed to this industry.

Due to the existence of a big amount of producers, particularly in China, the industry is extremely divided in nature. Competitive business competition is strong due to increased R&D investments in product development and increased consumer effectiveness. High competition in product final rates and the concentrate on the use of natural ingredients by producers thus denotes elevated market rivalry.

Market Segment Analysis:

Acumen Research report focuses on market attractiveness by assessing the key market segments. The report also combines region-wise segments for a better understanding of the supply and demand ratio of this market. This exclusive study of the report analyzes the present and future market scenario and the industry trends that are influencing the growth of the segments. Besides, the report also covers the value chain analysis, supply chain analysis, and year-on-year basis analysis of this market.

Market Segmentation

Market, by Source

• Bovine
  • Personal Care & Cosmetics
  • Pharmaceuticals
  • Nutraceuticals
  • Animal Feed
  • Others
• Swine
  • Personal Care & Cosmetics
  • Pharmaceuticals
  • Nutraceuticals
  • Animal Feed
  • Others
• Poultry
  • Personal Care & Cosmetics
  • Pharmaceuticals
  • Nutraceuticals
  • Animal Feed
  • Others
• Shark
  • Personal Care & Cosmetics
  • Pharmaceuticals
  • Nutraceuticals
  • Animal Feed
  • Others
• Synthetic
  • Personal Care & Cosmetics
  • Pharmaceuticals
  • Nutraceuticals
  • Animal Feed
  • Others

Market, by Application

• Dietary Supplements
• Pharmaceutical
• Cosmetics
• Veterinary Use

TABLE OF CONTENT

​CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Chondroitin Sulfate
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Chondroitin Sulfate Market By Source
1.2.2.1. Global Chondroitin Sulfate Market Revenue and Growth Rate Comparison By Source (2015-2026)
1.2.2.2. Global Chondroitin Sulfate Market Revenue Share By Source in 2018
1.2.2.3. Bovine
1.2.2.3.1. Personal Care & Cosmetics
1.2.2.3.2. Pharmaceuticals
1.2.2.3.3. Nutraceuticals
1.2.2.3.4. Animal Feed
1.2.2.3.5. Others
1.2.2.4. Swine
1.2.2.4.1. Personal Care & Cosmetics
1.2.2.4.2. Pharmaceuticals
1.2.2.4.3. Nutraceuticals
1.2.2.4.4. Animal Feed
1.2.2.4.5. Others
1.2.2.5. Poultry
1.2.2.5.1. Personal Care & Cosmetics
1.2.2.5.2. Pharmaceuticals
1.2.2.5.3. Nutraceuticals
1.2.2.5.4. Animal Feed
1.2.2.5.5. Others
1.2.2.6. Shark
1.2.2.6.1. Personal Care & Cosmetics
1.2.2.6.2. Pharmaceuticals
1.2.2.6.3. Nutraceuticals
1.2.2.6.4. Animal Feed
1.2.2.6.5. Others
1.2.2.7. Synthetic
1.2.2.7.1. Personal Care & Cosmetics
1.2.2.7.2. Pharmaceuticals
1.2.2.7.3. Nutraceuticals
1.2.2.7.4. Animal Feed
1.2.2.7.5. Others

1.2.3. Chondroitin Sulfate Market By Application
1.2.3.1. Global Chondroitin Sulfate Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Global Chondroitin Sulfate Market Revenue Share By Application in 2018
1.2.3.3. Dietary Supplements
1.2.3.4. Pharmaceutical
1.2.3.5. Cosmetics
1.2.3.6. Veterinary Use
1.2.4. Chondroitin Sulfate Market by Geography
1.2.4.1. Global Chondroitin Sulfate Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Chondroitin Sulfate Market Revenue and Growth Rate(2015-2026)
1.2.4.3. Europe Chondroitin Sulfate Market Revenue and Growth Rate(2015-2026)
1.2.4.4. Asia-Pacific Chondroitin Sulfate Market Revenue and Growth Rate(2015-2026)
1.2.4.5. Latin America Chondroitin Sulfate Market Revenue and Growth Rate(2015-2026)
1.2.4.6. Middle East and Africa (MEA) Chondroitin Sulfate Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Chondroitin Sulfate Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Chondroitin Sulfate Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Chondroitin Sulfate Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Chondroitin Sulfate Major Manufacturers in 2018

CHAPTER 4. CHONDROITIN SULFATE MARKET BY SOURCE
4.1. Global Chondroitin Sulfate Revenue By Source
4.2. Bovine
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.2.1. Personal Care & Cosmetics
4.2.2.2. Pharmaceuticals
4.2.2.3. Nutraceuticals
4.2.2.4. Animal Feed
4.2.2.5. Others
4.3. Swine
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.2.1. Personal Care & Cosmetics
4.3.2.2. Pharmaceuticals
4.3.2.3. Nutraceuticals
4.3.2.4. Animal Feed
4.3.2.5. Others
4.4. Poultry
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4.2.1. Personal Care & Cosmetics
4.4.2.2. Pharmaceuticals
4.4.2.3. Nutraceuticals
4.4.2.4. Animal Feed
4.4.2.5. Others
4.5. Shark
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5.2.1. Personal Care & Cosmetics
4.5.2.2. Pharmaceuticals
4.5.2.3. Nutraceuticals
4.5.2.4. Animal Feed
4.5.2.5. Others
4.6. Synthetic
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6.2.1. Personal Care & Cosmetics
4.6.2.2. Pharmaceuticals
4.6.2.3. Nutraceuticals
4.6.2.4. Animal Feed
4.6.2.5. Others

CHAPTER 5. CHONDROITIN SULFATE MARKET BY APPLICATION
5.1. Global Chondroitin Sulfate Revenue By Application
5.2. Dietary Supplements
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Pharmaceutical
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Cosmetics
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Veterinary Use
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA CHONDROITIN SULFATE MARKET BY COUNTRY
6.1. North America Chondroitin Sulfate Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Chondroitin Sulfate Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Chondroitin Sulfate Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE CHONDROITIN SULFATE MARKET BY COUNTRY
7.1. Europe Chondroitin Sulfate Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Chondroitin Sulfate Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC CHONDROITIN SULFATE MARKET BY COUNTRY
8.1. Asia-Pacific Chondroitin Sulfate Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Chondroitin Sulfate Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA CHONDROITIN SULFATE MARKET BY COUNTRY
9.1. Latin America Chondroitin Sulfate Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Chondroitin Sulfate Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Mexico
9.4.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST CHONDROITIN SULFATE MARKET BY COUNTRY
10.1. Middle East Chondroitin Sulfate Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Chondroitin Sulfate Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA CHONDROITIN SULFATE MARKET BY COUNTRY
11.1. Africa Chondroitin Sulfate Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Chondroitin Sulfate Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Bioiberica S.A.U.
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Qingdao Wan tulmin Biological Products Co. Ltd.
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Sigma-Aldrich, Inc.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. HeBeiSanXin Industrial Group
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Sino Siam Biotechnique Company Limited
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Bio-gen Extracts Private Limited
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. TSI Group Ltd.
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. ZPD
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. SEIKAGAKU CORPORATION
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Others
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report @ https://www.acumenresearchandconsulting.com/buy-now/0/1558